AlphaPrime: Using AI to turbocharge clinical trial processes · TechNode

By A Mystery Man Writer

Sharon Chen is the CEO of AlphaPrime, a global health technology company. Prior to founding AlphaPrime, Sharon was the head of Verily China (Alphabet’s

Two-minute Daily AI Update (Date: 03/05/2024): News from Anthropic, Stability AI, Cloudflare, ChatGPT, Wix, , Groq, and more : r/ArtificialInteligence

KN019-Alphamab Oncology

Netramark unveils ChatGPT-based trial de-risking technology

Insilico Medicine achieves AI drug discovery breakthrough

Avidity Biosciences announces Phase 1/2 trial for FSHD

How does Claude, the new LLM from Anthropic compare to ChatGPT? A serious contender, by Cerebrium

Telitacicept: First Approval

Sally Ann Frank on LinkedIn: AlphaPrime: Using AI to turbocharge clinical trial processes · TechNode

D-FW biotech firm completes “first ever” AI clinical trial

TechNode

Branded Content Archives · TechNode

Alice Hsu on LinkedIn: AlphaPrime: Using Al to turbocharge clinical trial processes

TechNode

Alice Hsu on LinkedIn: AlphaPrime: Using Al to turbocharge clinical trial processes

©2016-2024, doctommy.com, Inc. or its affiliates